Lupin gets warning letter from US FDA for Mandideep facility Press Trust of India Sep 19, 2019 Lupin said there are no drug master file and abbreviated new drug applications (ANDA) pending review or approval from the…
US FDA raises concerns over Lupin’s plant at Pithampur Usha Sharma Feb 24, 2015 FDA inspected the plant in January this year and listed six observations on the manufacturing processes at the plant
